BMJ Retracts PREVENT-TAHA8 Stem Cell Heart Failure Trial
The BMJ has retracted the PREVENT-TAHA8 phase 3 trial on mesenchymal stem cells for heart failure due to data integrity and enrollment concerns.
By James Liu
Cardiology
The latest cardiology coverage from Hawaii Medical Journal.
Microbial Resistance Patterns in Combat-Related Wounds: Clinical Insights from the Ukrainian Conflict for Emergency and Trauma Care
Analysis of microbial flora in war wounds from Ukrainian front-line casualties reveals concerning antimicrobial resistance patterns with implications for combat casualty care and civilian trauma management.